The Company was founded by Dr. Sayed Shaker in 1983. Currently, in Egypt, Dr. Sayed's son, Amr Shaker (the Sponsor) along with his family own 100% of Egyptian Company for Medical Industries (EGF), Egyptian Group for Exports & Imports (EGI), Egyptian Group for Corporate Services (EGCS), and 50% of Fresenius Medical Care Egypt (FMCEG) (collectively known as “EGMED”). Regionally, the Shaker family will own 100% of entities created for the expansion into East Africa. As part of this transaction, the group of Companies will be restructured into a Holding Company that will directly or indirectly mirror the above ownership stakes.

IFC’s investment is an up to USD15M Unsecured Income Participating Long-term Loan (the “C Loan”).

Egypt 19 Ebad El Rahman St. Heliopolis Cairo, Egypt.

As of December 2024, EGMED operates four manufacturing plants in Cairo, Egypt in addition to nine distribution centers.

The above address is the Head Office in Egypt.                                      

This is only applicable for extractives industry.

EGMED is found to be strongly committed to developing a robust Governance structure based on global best practices and recommendations from IFC. EGMED’s Governance does not pose any material risks to Development Impacts.         

  This is a Category B project according to IFC’s Policy on Environmental and Social Sustainability because EGMED’s business activities have limited adverse E&S risks or impacts that are few in number, generally site-specific, largely reversible, and readily avoided by implementing mitigation measures. Key E&S issues included: (a) the company’s ESMS and organizational capacity to manage operations in line with IFC PSs; (b) adequate E&S risk assessments and management of the proposed operations; (c) assurance of fair, safe and healthy working conditions for employees in line with IFC PSs especially on gender-based violence (GBV); (d) energy efficiency of the operations; (e) community health, safety and security and community grievance mechanism.